• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例继发于社会经济挑战和不依从性的复发性心肌梗死病例研究:出院前筛查

A case study of recurrent myocardial infarction secondary to socioeconomic challenges and nonadherence: Pre-discharge screening.

作者信息

Kosaraju Revanth, Natour Sami, Yuan Stanley, Cho Geoffrey

机构信息

David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Internal Medicine Residency Program, UCLA Health, Los Angeles, CA, USA.

出版信息

SAGE Open Med Case Rep. 2023 Mar 21;11:2050313X231162921. doi: 10.1177/2050313X231162921. eCollection 2023.

DOI:10.1177/2050313X231162921
PMID:36968994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10034268/
Abstract

Medication nonadherence following myocardial infarction (MI) is prevalent and increases the risk of recurrent cardiovascular events. Socioeconomic factors including medication cost, financial insecurity, and poor health literacy are associated with nonadherence. We present a patient with a history of recurrent MI who was nonadherent due to socioeconomic challenges. Our patient subsequently developed ST-elevation MI secondary to in-stent thrombosis. This case illustrates the importance of pre-discharge screening for barriers to adherence.

摘要

心肌梗死(MI)后药物治疗依从性不佳的情况很普遍,且会增加心血管事件复发的风险。包括药物成本、经济不安全和健康素养低下等在内的社会经济因素与依从性不佳有关。我们介绍一位有复发性心肌梗死病史的患者,他因社会经济挑战而未坚持服药。我们的患者随后因支架内血栓形成继发ST段抬高型心肌梗死。该病例说明了出院前筛查依从性障碍的重要性。

相似文献

1
A case study of recurrent myocardial infarction secondary to socioeconomic challenges and nonadherence: Pre-discharge screening.一例继发于社会经济挑战和不依从性的复发性心肌梗死病例研究:出院前筛查
SAGE Open Med Case Rep. 2023 Mar 21;11:2050313X231162921. doi: 10.1177/2050313X231162921. eCollection 2023.
2
The association of pre- and posthospital medication adherence in myocardial infarction patients.心肌梗死患者住院前后用药依从性的相关性。
Am Heart J. 2019 Feb;208:74-80. doi: 10.1016/j.ahj.2018.11.004. Epub 2018 Nov 15.
3
Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction.双重符合医疗保险-医疗补助资格的成年人心肌梗死的治疗、结果和药物治疗方案的依从性。
JAMA Cardiol. 2016 Oct 1;1(7):787-794. doi: 10.1001/jamacardio.2016.2724.
4
Timing and long-term prognosis of recurrent MI after primary angioplasty : Stent thrombosis vs. non-stent-related reinfarction.直接经皮冠状动脉腔内血管成形术后复发性心肌梗死的时间及长期预后:支架血栓形成与非支架相关再梗死
Herz. 2017 Apr;42(2):186-193. doi: 10.1007/s00059-016-4446-0. Epub 2016 Jun 30.
5
Association between perceived life chaos and medication adherence in a postmyocardial infarction population.心肌梗死后人群中感知到的生活混乱与药物依从性之间的关联。
Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):619-25. doi: 10.1161/CIRCOUTCOMES.113.000435. Epub 2013 Nov 12.
6
Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.随机比较依维莫司洗脱支架和西罗莫司洗脱支架在 ST 段抬高型心肌梗死患者中的应用:RACES-MI 试验。
JACC Cardiovasc Interv. 2014 Aug;7(8):849-56. doi: 10.1016/j.jcin.2014.02.016.
7
Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.经血管造影证实患有冠状动脉疾病的老年ST段抬高型与非ST段抬高型心肌梗死患者的短期和长期预后差异。
Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):513-22. doi: 10.1161/CIRCOUTCOMES.115.002312. Epub 2016 Sep 6.
8
Cognitive dysfunction and poor health literacy are common in veterans presenting with acute coronary syndrome: insights from the MEDICATION study.认知功能障碍和健康素养低下在急性冠状动脉综合征退伍军人中很常见:来自MEDICATION研究的见解。
Patient Prefer Adherence. 2015 Jun 8;9:745-51. doi: 10.2147/PPA.S75110. eCollection 2015.
9
The efficacy of everolimus-eluting stent implantation in patients with ST-segment elevation myocardial infarction: outcomes of 2-year clinical follow-up.依维莫司洗脱支架植入术治疗ST段抬高型心肌梗死患者的疗效:2年临床随访结果
Heart Vessels. 2016 Oct;31(10):1609-15. doi: 10.1007/s00380-015-0783-9. Epub 2015 Dec 19.
10
Predictors of Recurrent Ischemic Events in Patients With ST-Segment Elevation Myocardial Infarction.ST 段抬高型心肌梗死患者复发性缺血事件的预测因素。
Am J Cardiol. 2021 Nov 15;159:44-51. doi: 10.1016/j.amjcard.2021.08.019. Epub 2021 Sep 7.

本文引用的文献

1
Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program.医疗保险处方药计划中钠-葡萄糖共转运蛋白 2 抑制剂和胰高血糖素样肽 1 受体激动剂的覆盖范围、处方限制和自付费用。
JAMA Netw Open. 2020 Oct 1;3(10):e2020969. doi: 10.1001/jamanetworkopen.2020.20969.
2
Prevalence of Screening for Food Insecurity, Housing Instability, Utility Needs, Transportation Needs, and Interpersonal Violence by US Physician Practices and Hospitals.美国医生诊所和医院对食品不安全、住房不稳定、公用事业需求、交通需求和人际暴力进行筛查的流行率。
JAMA Netw Open. 2019 Sep 4;2(9):e1911514. doi: 10.1001/jamanetworkopen.2019.11514.
3
Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan Under Medicare Part D.医疗保险部分 D 下沙库巴曲缬沙坦的国家覆盖范围和自付费用评估。
JAMA Cardiol. 2019 Aug 1;4(8):828-830. doi: 10.1001/jamacardio.2019.2223.
4
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial.药物共付券对心肌梗死患者使用 P2Y12 抑制剂和主要心血管不良事件的影响:ARTEMIS 随机临床试验。
JAMA. 2019 Jan 1;321(1):44-55. doi: 10.1001/jama.2018.19791.
5
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016.2008-2016 年经皮冠状动脉介入治疗后抗血小板药物初治患者中血小板二磷酸腺苷 P2Y12 受体抑制剂的使用和依从性趋势。
JAMA Intern Med. 2018 Jul 1;178(7):943-950. doi: 10.1001/jamainternmed.2018.0783.
6
Hospital evaluation of health literacy and associated outcomes in patients after acute myocardial infarction.医院对急性心肌梗死后患者健康素养及其相关结局的评估。
Am Heart J. 2018 Apr;198:97-107. doi: 10.1016/j.ahj.2017.08.024. Epub 2017 Sep 2.
7
Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.急性心肌梗死后二级预防药物的持续使用情况:来自TRANSLATE-ACS研究的见解。
Am Heart J. 2015 Jul;170(1):62-9. doi: 10.1016/j.ahj.2015.03.019. Epub 2015 Apr 2.
8
Non-adherence to cardiovascular medications.心血管药物治疗不依从。
Eur Heart J. 2014 Dec 7;35(46):3267-76. doi: 10.1093/eurheartj/ehu364. Epub 2014 Sep 28.
9
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140. doi: 10.1016/j.jacc.2012.11.019. Epub 2012 Dec 17.
10
Full coverage for preventive medications after myocardial infarction.心肌梗死后的预防性药物全覆盖。
N Engl J Med. 2011 Dec 1;365(22):2088-97. doi: 10.1056/NEJMsa1107913. Epub 2011 Nov 14.